Smith, Graham & Co., Investment Advisors, LP Opko Health, Inc. Transaction History

Smith, Graham & Co., Investment Advisors, LP

$867 Million
Q4 2023

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 18, 2018	SELL	$3.11 - $5.12 $1.89 Million - $3.11 Million	-607,102 Closed	0 $0
Q4 2017 Jan 22, 2018	BUY	$4.61 - $7.04 $54,029 - $82,508	11,720 Added 1.97%	607,102 $2.98 Million
Q3 2017 Oct 19, 2017	BUY	$5.88 - $7.11 $3.5 Million - $4.23 Million	595,382	595,382 $4.08 Million

Others Institutions Holding OPK

# of Institutions

255

Shares Held

187M

Call Options Held

6.03M

Put Options Held

10.1M

Rubric Capital Management LP New York, NY

48.7M
Shares

$75 Million
2.02% of portfolio
Black Rock Inc. New York, NY

29.2M
Shares

$45 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

29.2M
Shares

$45 Million
0.0% of portfolio
State Street Corp Boston, MA

8.72M
Shares

$13.4 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

8.37M
Shares

$12.9 Million
0.0% of portfolio

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.19B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Graham & Co., Investment Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Graham & Co., Investment Advisors, LP with notifications on news.

Account